APO RESEARCH · REPORT
Transcriptomics
Transcriptomic incorporates the exploration and assortment of transcriptomes and finds diverse applications, chiefly in molecular genetics. The global transcriptomic market could see a whole lot of instances of new product launch. For example, Trio RNA-Seq launched by NuGEN Technologies, Inc. is particularly suited for low abundance transcripts applications as it offers an extremely sensitive whole transcriptomic solution. This innovation embodies three powerful technologies, viz. single primer isothermal amplification (SPIA), DimerFree, and AnyDeplete, for performing high sensitivity ribonucleic acid (RNA) analysis.
Product & engineering
Understand the product.
Transcriptomic incorporates the exploration and assortment of transcriptomes and finds diverse applications, chiefly in molecular genetics. The global transcriptomic market could see a whole lot of instances of new product launch. For example, Trio RNA-Seq launched by NuGEN Technologies, Inc. is particularly suited for low abundance transcripts applications as it offers an extremely sensitive whole transcriptomic solution. This innovation embodies three powerful technologies, viz. single primer isothermal amplification (SPIA), DimerFree, and AnyDeplete, for performing high sensitivity ribonucleic acid (RNA) analysis.
Selected research
Industry Growth & Trends
Global Transcriptomics Industry Growth and Trends Forecast to 2032
Market perspective
Transcriptomic incorporates the exploration and assortment of transcriptomes and finds diverse applications, chiefly in molecular genetics. The global transcriptomic market could see a whole lot of instances of new product launch. For example, Trio RNA-Seq launched by NuGEN Technologies, Inc. is particularly suited for low abundance transcripts applications as it offers an extremely sensitive whole transcriptomic solution. This innovation embodies three powerful technologies, viz. single primer isothermal amplification (SPIA), DimerFree, and AnyDeplete, for performing high sensitivity ribonucleic acid (RNA) analysis.
According to APO Research, the global Transcriptomics market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
Report Scope
Read the full market overview
This report provides a structured, data-driven view of the global Transcriptomics market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Transcriptomics market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Transcriptomics market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Transcriptomics.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading companies in the global Transcriptomics market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Transcriptomics Market by Company
Thermo Fisher Scientific
Illumina
QIAGEN (Exiqon)
Agilent Technologies
Roche
GE Healthcare
Bio-Rad Laboratories
Fluidigm
Transcriptomics Segment by Type
PCR
Microarray
Sequencing
Transcriptomics Segment by Application
Pharmaceutical and Biotechnology
Academic Research and Government Institutes
Hospitals and Diagnostic Centers
Transcriptomics Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Transcriptomics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Transcriptomics and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Transcriptomics.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of Transcriptomics companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- PCR
- Microarray
- Sequencing
Applications
- Pharmaceutical and Biotechnology
- Academic Research and Government Institutes
- Hospitals and Diagnostic Centers
Companies covered
- Thermo Fisher Scientific
- Illumina
- QIAGEN (Exiqon)
- Agilent Technologies
- Roche
- GE Healthcare
- Bio-Rad Laboratories
- Fluidigm
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.3 Global Transcriptomics Market Size Overview by Region 2021 VS 2025 VS 2032
- 1.4 Global Transcriptomics Market Size by Region (2021-2032)
- 1.4.1 Global Transcriptomics Market Size by Region (2021-2026)
- 1.4.2 Global Transcriptomics Market Size by Region (2027-2032)
- 1.5 Key Regions Transcriptomics Market Size (2021-2032)
- 1.5.1 North America Transcriptomics Market Size Growth Rate (2021-2032)
- 1.5.2 Europe Transcriptomics Market Size Growth Rate (2021-2032)
- 1.5.3 Asia-Pacific Transcriptomics Market Size Growth Rate (2021-2032)
- 1.5.4 South America Transcriptomics Market Size Growth Rate (2021-2032)
- 1.5.5 Middle East & Africa Transcriptomics Market Size Growth Rate (2021-2032)
2 Transcriptomics Market by Type
- 2.1 Type Introduction
- 2.1.1 PCR
- 2.1.2 Microarray
- 2.1.3 Sequencing
- 2.2 Global Transcriptomics Market Size by Type
- 2.2.1 Global Transcriptomics Market Size Overview by Type (2021-2032)
- 2.2.2 Global Transcriptomics Historic Market Size Review by Type (2021-2026)
- 2.2.3 Global Transcriptomics Market Size Forecasted by Type (2027-2032)
- 2.3 Global Transcriptomics Market Size by Regions
- 2.3.1 North America Transcriptomics Market Size Breakdown by Type (2021-2026)
- 2.3.2 Europe Transcriptomics Market Size Breakdown by Type (2021-2026)
- 2.3.3 Asia-Pacific Transcriptomics Market Size Breakdown by Type (2021-2026)
- 2.3.4 South America Transcriptomics Market Size Breakdown by Type (2021-2026)
- 2.3.5 Middle East and Africa Transcriptomics Market Size Breakdown by Type (2021-2026)
3 Transcriptomics Market by Application
- 3.1 Type Introduction
- 3.1.1 Pharmaceutical and Biotechnology
- 3.1.2 Academic Research and Government Institutes
- 3.1.3 Hospitals and Diagnostic Centers
- 3.2 Global Transcriptomics Market Size by Application
- 3.2.1 Global Transcriptomics Market Size Overview by Application (2021-2032)
- 3.2.2 Global Transcriptomics Historic Market Size Review by Application (2021-2026)
- 3.2.3 Global Transcriptomics Market Size Forecasted by Application (2027-2032)
- 3.3 Global Transcriptomics Market Size by Regions
- 3.3.1 North America Transcriptomics Market Size Breakdown by Application (2021-2026)
- 3.3.2 Europe Transcriptomics Market Size Breakdown by Application (2021-2026)
- 3.3.3 Asia-Pacific Transcriptomics Market Size Breakdown by Application (2021-2026)
- 3.3.4 South America Transcriptomics Market Size Breakdown by Application (2021-2026)
- 3.3.5 Middle East and Africa Transcriptomics Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
- 4.1 Transcriptomics Industry Trends
- 4.2 Transcriptomics Industry Drivers
- 4.3 Transcriptomics Industry Opportunities and Challenges
- 4.4 Transcriptomics Industry Restraints
5 Competitive Insights by Company
- 5.1 Global Top Players by Transcriptomics Revenue (2021-2026)
- 5.2 Global Transcriptomics Industry Company Ranking, 2024 VS 2025 VS 2026
- 5.3 Global Transcriptomics Key Company Headquarters & Area Served
- 5.4 Global Transcriptomics Company, Product Type & Application
- 5.5 Global Transcriptomics Company Commercialization Time
- 5.6 Market Competitive Analysis
- 5.6.1 Global Transcriptomics Market CR5 and HHI
- 5.6.2 Global Top 5 and 10 Transcriptomics Players Market Share by Revenue in 2025
- 5.6.3 2025 Transcriptomics Tier 1, Tier 2, and Tier 3
6 Company Profiles
- 6.1 Thermo Fisher Scientific
- 6.1.1 Thermo Fisher Scientific Company Information
- 6.1.2 Thermo Fisher Scientific Business Overview
- 6.1.3 Thermo Fisher Scientific Transcriptomics Revenue, Global Share and Gross Margin (2021-2026)
- 6.1.4 Thermo Fisher Scientific Transcriptomics Product Portfolio
- 6.1.5 Thermo Fisher Scientific Recent Developments
- 6.2 Illumina
- 6.2.1 Illumina Company Information
- 6.2.2 Illumina Business Overview
- 6.2.3 Illumina Transcriptomics Revenue, Global Share and Gross Margin (2021-2026)
- 6.2.4 Illumina Transcriptomics Product Portfolio
- 6.2.5 Illumina Recent Developments
- 6.3 QIAGEN (Exiqon)
- 6.3.1 QIAGEN (Exiqon) Company Information
- 6.3.2 QIAGEN (Exiqon) Business Overview
- 6.3.3 QIAGEN (Exiqon) Transcriptomics Revenue, Global Share and Gross Margin (2021-2026)
- 6.3.4 QIAGEN (Exiqon) Transcriptomics Product Portfolio
- 6.3.5 QIAGEN (Exiqon) Recent Developments
- 6.4 Agilent Technologies
- 6.4.1 Agilent Technologies Company Information
- 6.4.2 Agilent Technologies Business Overview
- 6.4.3 Agilent Technologies Transcriptomics Revenue, Global Share and Gross Margin (2021-2026)
- 6.4.4 Agilent Technologies Transcriptomics Product Portfolio
- 6.4.5 Agilent Technologies Recent Developments
- 6.5 Roche
- 6.5.1 Roche Company Information
- 6.5.2 Roche Business Overview
- 6.5.3 Roche Transcriptomics Revenue, Global Share and Gross Margin (2021-2026)
- 6.5.4 Roche Transcriptomics Product Portfolio
- 6.5.5 Roche Recent Developments
- 6.6 GE Healthcare
- 6.6.1 GE Healthcare Company Information
- 6.6.2 GE Healthcare Business Overview
- 6.6.3 GE Healthcare Transcriptomics Revenue, Global Share and Gross Margin (2021-2026)
- 6.6.4 GE Healthcare Transcriptomics Product Portfolio
- 6.6.5 GE Healthcare Recent Developments
- 6.7 Bio-Rad Laboratories
- 6.7.1 Bio-Rad Laboratories Company Information
- 6.7.2 Bio-Rad Laboratories Business Overview
- 6.7.3 Bio-Rad Laboratories Transcriptomics Revenue, Global Share and Gross Margin (2021-2026)
- 6.7.4 Bio-Rad Laboratories Transcriptomics Product Portfolio
- 6.7.5 Bio-Rad Laboratories Recent Developments
- 6.8 Fluidigm
- 6.8.1 Fluidigm Company Information
- 6.8.2 Fluidigm Business Overview
- 6.8.3 Fluidigm Transcriptomics Revenue, Global Share and Gross Margin (2021-2026)
- 6.8.4 Fluidigm Transcriptomics Product Portfolio
- 6.8.5 Fluidigm Recent Developments
7 North America
- 7.1 North America Transcriptomics Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2 North America Transcriptomics Market Size by Country (2021-2026)
- 7.3 North America Transcriptomics Market Size Forecast by Country (2027-2032)
8 Europe
- 8.1 Europe Transcriptomics Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2 Europe Transcriptomics Market Size by Country (2021-2026)
- 8.3 Europe Transcriptomics Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific Transcriptomics Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2 Asia-Pacific Transcriptomics Market Size by Country (2021-2026)
- 9.3 Asia-Pacific Transcriptomics Market Size Forecast by Country (2027-2032)
10 South America
- 10.1 South America Transcriptomics Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2 South America Transcriptomics Market Size by Country (2021-2026)
- 10.3 South America Transcriptomics Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa Transcriptomics Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2 Middle East & Africa Transcriptomics Market Size by Country (2021-2026)
- 11.3 Middle East & Africa Transcriptomics Market Size Forecast by Country (2027-2032)
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst